Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™
Quantum-Si (Nasdaq: QSI) has been awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award in North America for its groundbreaking Platinum® instrument, the first benchtop sequencer offering single-molecule protein sequencing at the amino acid level. The technology enables deep insights into protein structure and function through a compact, accessible, and cost-effective instrument. The Platinum device integrates proprietary image sensors for single-molecule detection and precision sequencing, making protein research more accessible to labs of all sizes. The company's innovation is backed by an extensive intellectual property portfolio of over 1,000 issued and pending patents.
Quantum-Si (Nasdaq: QSI) ha ricevuto il premio per l'Innovazione Tecnologica 2024 di Frost & Sullivan in Nord America per il suo innovativo strumento Platinum®, il primo sequenziatore da banco che offre il sequenziamento di proteine a singola molecola a livello di aminoacidi. La tecnologia consente di ottenere approfondimenti approfonditi sulla struttura e sulla funzione delle proteine grazie a uno strumento compatto, accessibile e conveniente. Il dispositivo Platinum integra sensori d'immagine proprietari per la rilevazione di singole molecole e un sequenziamento preciso, rendendo la ricerca sulle proteine più accessibile per i laboratori di tutte le dimensioni. L'innovazione dell'azienda è sostenuta da un ampio portafoglio di proprietà intellettuale di oltre 1.000 brevetti concessi e in attesa.
Quantum-Si (Nasdaq: QSI) ha sido galardonado con el Premio a la Innovación Tecnológica 2024 de Frost & Sullivan en América del Norte por su innovador instrumento Platinum®, el primer secuenciador de banco que ofrece secuenciación de proteínas a molécula única a nivel de aminoácidos. La tecnología permite obtener conocimientos profundos sobre la estructura y función de las proteínas a través de un instrumento compacto, accesible y rentable. El dispositivo Platinum integra sensores de imagen patentados para la detección de moléculas individuales y secuenciación precisa, haciendo que la investigación de proteínas sea más accesible para laboratorios de todos los tamaños. La innovación de la compañía está respaldada por un extenso portafolio de propiedad intelectual de más de 1,000 patentes emitidas y pendientes.
Quantum-Si (Nasdaq: QSI)는 혁신적인 Platinum® 장비
Quantum-Si (Nasdaq: QSI) a reçu le prix Frost & Sullivan de l'Innovation Technologique 2024 en Amérique du Nord pour son innovant instrument Platinum®, le premier séquenceur de paillasse offrant un séquençage de protéines à molécule unique au niveau des acides aminés. Cette technologie permet d'obtenir des insights approfondis sur la structure et la fonction des protéines grâce à un instrument compact, accessible et économique. Le dispositif Platinum intègre des capteurs d'image propriétaires pour la détection de molécules uniques et le séquençage précis, rendant la recherche sur les protéines plus accessible aux laboratoires de toutes tailles. L'innovation de l'entreprise est soutenue par un large portefeuille de propriété intellectuelle de plus de 1 000 brevets délivrés et en attente.
Quantum-Si (Nasdaq: QSI) wurde mit dem Frost & Sullivan Technology Innovation Leadership Award 2024 für Nordamerika für sein bahnbrechendes Platinum®-Instrument ausgezeichnet, dem ersten Tischsequenzierer, der eine Einzelmolekül-Proteinsequenzierung auf Aminosäureebene bietet. Diese Technologie ermöglicht tiefgreifende Einblicke in die Struktur und Funktion von Proteinen durch ein kompaktes, zugängliches und kosteneffizientes Instrument. Das Platinum-Gerät integriert proprietäre Bildsensoren zur Einzelmoleküldetektion und präzisen Sequenzierung, wodurch die Proteinforschung für Labore aller Größenordnungen zugänglicher wird. Die Innovation des Unternehmens wird von einem umfangreichen Portfolio an geistigem Eigentum mit über 1.000 erteilten und anhängigen Patenten unterstützt.
- First-to-market with benchtop single-molecule protein sequencer
- Strong intellectual property portfolio with over 1,000 patents
- Cost-effective solution enabling in-house protein research
- Recognition from Frost & Sullivan validates technology leadership
- None.
Frost & Sullivan’s independent team of experts selected QSI for this honor based on the company’s pioneering technology and commitment to advancing proteomics. The Platinum instrument addresses a crucial need for high-resolution protein sequencing by enabling deep insights into protein structure and function within a compact, accessible, and cost-effective instrument. This technology brings single-molecule protein sequencing into labs of all sizes, transforming the way researchers can explore protein variants, modifications, and interactions without the complex workflows and high costs traditionally associated with protein analysis.
“Receiving Frost & Sullivan’s 2024 Technology Innovation Leadership Award is a testament to our team’s dedication to advancing the proteomics field,” said Jeff Hawkins, CEO of Quantum-Si. “The Platinum instrument enables researchers to achieve unprecedented insights at the amino acid level, empowering both core and non-core labs to drive scientific discovery faster and more efficiently.”
Quantum-Si’s Platinum instrument integrates unique engineering solutions, including proprietary image sensors that enable single-molecule detection and precision sequencing. It captures fluorescence signals from each amino acid binding event, providing an end-to-end solution for direct protein sequencing with high accuracy. The device’s affordability and compact design allow more labs to bring proteomic research in-house, reducing dependence on costly external resources and enhancing productivity.
Frost & Sullivan’s analysis highlights Quantum-Si’s strong commitment to innovation and operational excellence, recognizing its extensive intellectual property portfolio with over 1,000 issued and pending patents. The award highlights QSI’s strategic approach to advancing technology that addresses the evolving needs of the proteomics field.
For more information on Quantum-Si’s technology and research applications, please visit The Protein Sequencing Company™ | Quantum-Si
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113522948/en/
Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP, Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
What award did Quantum-Si (QSI) receive in 2024?
What is unique about Quantum-Si's (QSI) Platinum® instrument?
How many patents does Quantum-Si (QSI) have in its portfolio?
